ArticleTherapeutic advances in hematology2026

Early-onset de novo donor-specific anti-HLA antibodies may contribute to poor graft function following haploidentical transplantation for myelodysplastic syndrome: a rare case presentation.

Xianbo Huang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.